BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12682634)

  • 1. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
    Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human AML cells in NOD/SCID mice: engraftment potential and gene expression.
    Lumkul R; Gorin NC; Malehorn MT; Hoehn GT; Zheng R; Baldwin B; Small D; Gore S; Smith D; Meltzer PS; Civin CI
    Leukemia; 2002 Sep; 16(9):1818-26. PubMed ID: 12200698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration.
    Nicolini FE; Cashman JD; Hogge DE; Humphries RK; Eaves CJ
    Leukemia; 2004 Feb; 18(2):341-7. PubMed ID: 14628073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M; Frankel A; Gerhard B; Hogge D
    Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
    Ailles LE; Gerhard B; Kawagoe H; Hogge DE
    Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia.
    Hogge DE; Feuring-Buske M; Gerhard B; Frankel AE
    Leuk Res; 2004 Nov; 28(11):1221-6. PubMed ID: 15380349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
    Rombouts WJ; Martens AC; Ploemacher RE
    Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
    Terpstra W; Prins A; Visser T; Wognum B; Wagemaker G; Löwenberg B; Wielenga J
    Leukemia; 1995 Sep; 9(9):1573-7. PubMed ID: 7658726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
    Monaco G; Konopleva M; Munsell M; Leysath C; Wang RY; Jackson CE; Korbling M; Estey E; Belmont J; Andreeff M
    Stem Cells; 2004; 22(2):188-201. PubMed ID: 14990858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.
    Thanopoulou E; Cashman J; Kakagianne T; Eaves A; Zoumbos N; Eaves C
    Blood; 2004 Jun; 103(11):4285-93. PubMed ID: 14962905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC
    Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE; Humphries RK; Thomas TE; Hogge DE
    Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
    Kawano N; Ishikawa F; Shimoda K; Yasukawa M; Nagafuji K; Miyamoto T; Baba E; Tanaka T; Yamasaki S; Gondo H; Otsuka T; Ohshima K; Shultz LD; Akashi K; Harada M
    Leukemia; 2005 Aug; 19(8):1384-90. PubMed ID: 15959532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
    Guan Y; Gerhard B; Hogge DE
    Blood; 2003 Apr; 101(8):3142-9. PubMed ID: 12468427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
    Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.